Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis patterns in papillary renal cell carcinoma are characterized by distinct tumor microenvironment infiltration landscapes. | Front Mol Biosci | 2022 | 36275614 | PubTator, text mining | PubMed |
| The cuproptosis-related gene signature serves as a potential prognostic predictor for ovarian cancer using bioinformatics analysis. | Ann Transl Med | 2022 | 36267774 | PubTator, text mining | PubMed |
| Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma. | Front Pharmacol | 2022 | 36267281 | PubTator, text mining | PubMed |
| Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis. | Front Genet | 2022 | 36263417 | PubTator, text mining | PubMed |
| Oxysterol misbalance critically contributes to Wilson disease pathogenesis. | Sci Adv | 2022 | 36260680 | PubTator, text mining | PubMed |
| Nonsense-mediated mRNA decay and metal ion homeostasis and detoxification in Saccharomyces cerevisiae. | Biometals | 2022 | 36255607 | PubTator, text mining | PubMed |
| Bioinformatics analysis identified immune infiltration, risk and drug prediction models of copper-induced death genes involved in salivary glands damage of primary Sjögren's syndrome. | Medicine (Baltimore) | 2022 | 36254059 | PubTator, text mining | PubMed |
| Laboratory and clinical evaluation of a microarray for the detection of ATP7B mutations in Wilson disease in China. | J Clin Lab Anal | 2022 | 36253962 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. | Front Mol Biosci | 2022 | 36250008 | PubTator, text mining | PubMed |
| A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer. | Front Immunol | 2022 | 36248908 | PubTator, text mining | PubMed |
| Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. | Front Immunol | 2022 | 36248822 | PubTator, text mining | PubMed |
| The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy. | Oxid Med Cell Longev | 2022 | 36238639 | PubTator, text mining | PubMed |
| Double trouble: combined large-cell neuroendocrine and small-cell lung carcinoma. | Transl Cancer Res | 2022 | 36237264 | PubTator, text mining | PubMed |
| Metallo-Drugs in Cancer Therapy: Past, Present and Future. | Molecules | 2022 | 36235023 | PubTator, text mining | PubMed |
Decreased Expression of the Slc31a1 Gene and Cytoplasmic Relocalization of Membrane CTR1 Protein in Renal Epithelial Cells: A Potent Protective Mechanism against Copper Nephrotoxicity in a Mouse Model of Menkes Disease. | Int J Mol Sci | 2022 | 36232742 | PubTator, text mining | PubMed |
| Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy. | Int J Mol Sci | 2022 | 36232561 | PubTator, text mining | PubMed |
| The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer. | Front Genet | 2022 | 36226193 | PubTator, text mining | PubMed |
| Cuproptosis-related gene signatures for predicting prognosis of lung adenocarcinoma. | Medicine (Baltimore) | 2022 | 36221373 | PubTator, text mining | PubMed |
| A pathological link between dysregulated copper binding in Cu/Zn-superoxide dismutase and amyotrophic lateral sclerosis. | J Clin Biochem Nutr | 2022 | 36213785 | PubTator, text mining | PubMed |
| Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma. | Pathol Oncol Res | 2022 | 36213162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=49